Literature DB >> 24900810

Halting HCV Replication with NS5A Inhibitors and NS5B Polymerase Inhibitors: Effective New Treatments of HCV Infection.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2013        PMID： 24900810      PMCID： PMC4027778          DOI： 10.1021/ml400456r

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.

Authors:  Nihar Shah; Tracey Pierce; Kris V Kowdley
Journal:  Expert Opin Investig Drugs       Date:  2013-06-04       Impact factor: 6.206

Review 2.  A review on an update of NS5B polymerase hepatitis C virus inhibitors.

Authors:  J Varshney; P K Sharma; A Sharma
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-05       Impact factor: 3.507

Review 3.  NS5A inhibitors in the treatment of hepatitis C.

Authors:  Jean-Michel Pawlotsky
Journal:  J Hepatol       Date:  2013-04-06       Impact factor: 25.083

Review 4.  The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection.

Authors:  Ralf Bartenschlager; Volker Lohmann; Francois Penin
Journal:  Nat Rev Microbiol       Date:  2013-06-10       Impact factor: 60.633

Review 5.  Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein.

Authors:  Oscar Belda; Paul Targett-Adams
Journal:  Virus Res       Date:  2012-09-23       Impact factor: 3.303

Review 6.  Hepatitis C therapy with HCV NS5B polymerase inhibitors.

Authors:  Vincent Soriano; Eugenia Vispo; Carmen de Mendoza; Pablo Labarga; Jose Vicente Fernandez-Montero; Eva Poveda; Ana Treviño; Pablo Barreiro
Journal:  Expert Opin Pharmacother       Date:  2013-04-27       Impact factor: 3.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.